Review of Parameters in Routing Protocols in Vehicular Ad-hoc Networks

Vehicular Ad_hoc Network  (VANET) is a sophisticated elegance of devoted cellular network that permits automobiles to intelligently communicate for different   roadside infrastructure. VANETs bring with it some of demanding situations associated with Quality of Service (QoS) and performance. QoS relies upon on many parameters which includes packet transport ratio, bandwidth, postpone variance, records latency, etc. This paper, discuss numerous troubles associated with latency records, bandwidth usage, and transport of packet in VANETs. The demanding situations have been recognized in offering security, reliability and confidentiality of posted records. Finally, numerous packages of VANETs also are introduced in the modern computing scenario

The pharmaceutical efferct of date palm fruit extract (Phoenix dactylifera L.) against amitraz-induced infertility in male rats

The present study was aimed to investigate the potential protective effect of aqueous extracts of the flesh of dates (Phoenix dactylifera L.) against amitraz-induced infertility in male rats.  100 male Sprague-Dawley rats (120-150 g) were used. The animals were randomly divided into 4 groups  as follows:  Group 1, control animals were given free access to food and water, group 2 received dates extract (1/10 w/v) , group 3   received 1/20 of LD50 amitraz and group 4 received dates extract and the same dose of amitraz as in group 3. Infertility was investigated by examining sperm count, viability, and motility. Estimated levels of testosterone, estradiol and histopathological analysis were also done. The present results showed significant decrease in sperms count,  motility and viability in  group III rats that received  amitraz (P<0.001), increased  percentage of sperm cell abnormalities and decreased serum estradiol and testosterone hormones to 49.8+3.2 and 1.5±0.20 ng/dL versus 56.7+2.4 and 3.3 ±0.37 ng/dL respectively  compared with control. Histopathological examination of the testes also showed marked degeneration of spermatogenic cells associated with interstitial necrosis and blood vessel congestion. Spermatogenic cells and cellular debris were present in the seminiferous tubules lumen associated with moderate degeneration of spermatogenic cells lining of some seminiferous tubules with interstitial diffuse edema. The current results documented that date palm fruit extract possessed an anti-oxidant and anti-infertility effect. We concluded  that amitraz-induced testis damage in rats can be ameliorated by administration of date palm fruit extract. Keywords: Amitraz, dates palm, testis, testosterone, infertility

REVIEW ON CHEMICAL CONSTITUENTS AND BIOLOGICAL ACTIVITIES OF GENUS RUMEX

Genus Rumex belongs to the family Polygonaceae that is distributed worldwide and used in the treatment of different illnesses. Different parts of this plant are employed in the treatment of a number of ailments such as diarrhea, jaundice, hypertension, dermatopathy and inflammation. It was reported that they possess anti-oxidative, antimicrobial, antiviral and anti-cancer activities due to the presence of several phenolic constituents, anthraquinones and flavonoids such as rutin, luteolin and apigenin. Flavonoids play an important role against cardiovascular diseases by reducing oxidation of low-density lipoproteins. This article covers most of constituents of plants of genus Rumex reported from 2001 up to 2022. Furthermore, the biological activities of plants of genus Rumex are presented

Haematologic Parameters In Acute Promyelocytic Leukemia Patients Treated With ALL Trans- Retinoic acid

Background: Acute Promyelocytic Leukemia (APL) is commonly associated with disseminated intravascular coagulation (DIC) and early correction of coagulopathy is of vital importance. All Trans-Retinoic Acid (ATRA) is considered to be the drug of choice in the treatment of APL.  Objective: The work was conducted to 1- Identify patients with APL who show laboratory evidence of DIC. 2- Study the serial changes in haemostatic parameters in APL patients treated with ATRA and to compare their results with those treated with conventional chemotherapy without ATRA. Subjective and methods: In this prospective study (from October 2003 to October 2005), 44 newly diagnosed, untreated APL patients were included. ATRA plus chemotherapy – treated patients were 24 while 17 patients were treated with chemotherapy other than ATRA. For each patient, a full clinical evaluation was done and hematological investigations were accomplished at time of diagnosis and repeated on day 3 and 7 of therapy. Diagnosis of DIC was based on finding a positive D- dimer test with hypofibrinogenaemia with or without pathologically prolonged (PT and/or APTT). Results: In 44 newly diagnosed, untreated APL patients studied, the age range between 6-81 years with a median of 27 years. Male to female ratio was 1.3:1. Before treatment all patients had anemia, thrombocytopenia, and elevated level of D – dimer. DIC was present in all patients at time of diagnosis. All parameters that showed abnormal level at time of diagnosis had returned to normality within one week in ATRA treated group, indicating that DIC has essentially resolved. By contrast, those parameters remained abnormal even on day 7 in the chemotherapy treated group. Indicating that DIC was on going. Conclusion: ATRA therapy in APL patients is associated with rapid improvement of coagulopathy therefore , it is justified to be used from day one of the treatment

Novel Polyepoxysuccinic Acid-Grafted Polyacrylamide as a Green Corrosion Inhibitor for Carbon Steel in Acidic Solution.

Utilizing green corrosion inhibitors has been classified among the most efficient and economical mitigation practices against metallic degradation and failure. This study aims to integrate the features of green and complementary properties of polyepoxysuccinic acid (PESA) and polyacrylamide (PAM) for steel corrosion inhibition. A novel PESA-grafted-PAM (PESAPAM) has been first-ever synthesized in this research study and deployed as a corrosion inhibitor for C-steel in 1.0 M HCl solution. Eco-toxicity prediction confirmed the environmentally friendly properties acquired by the synthesized inhibitor. Electrochemical, kinetics, and surface microscopic studies were carried out to gain a holistic view of C-steel corrosion behavior with the PESAPAM. Furthermore, the performance of PESAPAM was compared with that of the pure PESA under the same testing conditions. Results revealed predominant inhibitive properties of PESAPAM with an inhibition efficiency (IE) reaching 90% at 500 mg·L at 25 °C. Grafting PAM onto the PESA chain showed an overall performance improvement of 109% from IE% of 43 to 90%. Electrochemical measurements revealed a charge transfer-controlled corrosion mechanism and the formation of a thick double layer on the steel surface. The potentiodynamic study classified PESAPAM as a mixed-type inhibitor. Furthermore, the investigation of C-steel corrosion kinetics with the presence of PESAPAM predicted an activation energy of 85 kJ·mol, correlated with a physical adsorption behavior. Finally, performed scanning electron microscopy and energy-dispersive X-ray analyses confirmed the adsorption of PESA and PESAPAM, with superior coverage of PESAPAM onto the steel surface.This work was made possible by the support of the Undergraduate Research Experience Program (UREP) from Qatar National Research Fund (QNRF), grant #UREP28-104-2-036. R.J. would like to acknowledge the support of Qatar University project, grant #QUCP-CENG-2021-03. The findings achieved herein are solely the responsibility of the authors. Central Laboratories Unit at Qatar University are acknowledged for providing facilities to perform SEM/EDX analyses. Qatar National Library (QNL) is acknowledged for providing open access funding

In-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of Alzheimer disease

BACKGROUND: Egyptians recognized the healing power of herbs and used them in their medicinal formulations. Nowadays, “Attarin” drug shops and the public use mainly the Unani medicinal system for treatment of their health problems including improvement of memory and old age related diseases. Numerous medicinal plants have been described in old literature of Arabic traditional medicine for treatment of Alzheimer’s disease (AD) (or to strengthen memory). METHODS: In this study, some of these plants were evaluated against three different preliminary bioassays related to AD to explore the possible way of their bio-interaction. Twenty three selected plants were extracted with methanol and screened in vitro against acetylcholinesterase (AChE) and cycloxygenase-1 (COX-1) enzymes. In addition, anti-oxidant activity using DPPH was determined. RESULTS: Of the tested plant extracts; Adhatoda vasica and Peganum harmala showed inhibitory effect on AChE at IC50 294 μg/ml and 68 μg/ml respectively. Moreover, A. vasica interacted reversibly with the enzyme while P. harmala showed irreversible inhibition. Ferula assafoetida (IC50 3.2 μg/ml), Syzygium aromaticum (34.9 μg/ml) and Zingiber officinalis (33.6 μg/ml) showed activity against COX-1 enzyme. Potent radical scavenging activity was demonstrated by three plant extracts Terminalia chebula (EC50 2.2 μg/ml), T. arjuna (3.1 μg/ml) and Emblica officinalis (6.3 μg/ml). CONCLUSION: Interestingly, differential results have been obtained which indicate the variability of the mode of actions for the selected plants. Additionally, the reversible interaction of A. vasica against AChE and the potent activity of F. assafoetida against COX-1 make them effective, new and promising agents for treatment of AD in the future, either as total extracts or their single bioactive constituents.Science and Technology Development Fund (STDF), Egypt (project number 251)http://www.biomedcentral.com/1472-6882/13/121am2014mn201

Design and implementation of the European-Mediterranean Postgraduate Programme on Organ Donation and Transplantation (EMPODaT) for Middle East/North Africa countries

This prospective study reports the design and results obtained after the EMPODaT project implementation. This project was funded by the Tempus programme of the European Commission with the objective to implement a common postgraduate programme on organ donation and transplantation (ODT) in six selected universities from Middle East/North Africa (MENA) countries (Egypt, Lebanon and Morocco). The consortium, coordinated by the University of Barcelona, included universities from Spain, Germany, Sweden and France. The first phase of the project was to perform an analysis of the current situation in the beneficiary countries, including existing training programmes on ODT, Internet connection, digital facilities and competences, training needs, and ODT activity and accreditation requirements. A total of 90 healthcare postgraduate students participated in the 1-year training programme (30 ECTS academic credits). The methodology was based on e-learning modules and face-to-face courses in English and French. Training activities were evaluated through pre- and post-tests, self-assessment activities and evaluation charts. Quality was assessed through questionnaires and semi-structured interviews. The project results on a reproducible and innovative international postgraduate programme, improvement of knowledge, satisfaction of the participants and confirms the need on professionalizing the activity as the cornerstone to ensure organ transplantation self-sufficiency in MENA countries

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017

A double burden of malnutrition occurs when individuals, household members or communities experience both undernutrition and overweight. Here, we show geospatial estimates of overweight and wasting prevalence among children under 5 years of age in 105 low- and middle-income countries (LMICs) from 2000 to 2017 and aggregate these to policy-relevant administrative units. Wasting decreased overall across LMICs between 2000 and 2017, from 8.4% (62.3 (55.1–70.8) million) to 6.4% (58.3 (47.6–70.7) million), but is predicted to remain above the World Health Organization’s Global Nutrition Target of <5% in over half of LMICs by 2025. Prevalence of overweight increased from 5.2% (30 (22.8–38.5) million) in 2000 to 6.0% (55.5 (44.8–67.9) million) children aged under 5 years in 2017. Areas most affected by double burden of malnutrition were located in Indonesia, Thailand, southeastern China, Botswana, Cameroon and central Nigeria. Our estimates provide a new perspective to researchers, policy makers and public health agencies in their efforts to address this global childhood syndemic

The global burden of cancer attributable to risk factors, 2010-19 : a systematic analysis for the Global Burden of Disease Study 2019

Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.Peer reviewe